Capecitabine pharmacogenetics: historical milestones and progress toward clinical implementation
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Pharmacogenomics - 17(2016), 15, Seite 1607-1610 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Syn, Nicholas [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
Capecitabine |
| doi: |
10.2217/pgs-2016-0133 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1986296938 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1986296938 | ||
| 003 | DE-627 | ||
| 005 | 20230517080015.0 | ||
| 007 | tu | ||
| 008 | 161202s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.2217/pgs-2016-0133 |2 doi | |
| 028 | 5 | 2 | |a PQ20170301 |
| 035 | |a (DE-627)OLC1986296938 | ||
| 035 | |a (DE-599)GBVOLC1986296938 | ||
| 035 | |a (PRQ)c1481-db1e38b866439c4ae4cb1d68f038dec933f6fdf540fc9a0608c492ef8a1b523e0 | ||
| 035 | |a (KEY)0406126820160000017001501607capecitabinepharmacogeneticshistoricalmilestonesan | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Syn, Nicholas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Capecitabine pharmacogenetics: historical milestones and progress toward clinical implementation |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a TYMS | |
| 650 | 4 | |a thymidylate synthase | |
| 650 | 4 | |a Hand-foot syndrome | |
| 650 | 4 | |a DPYD | |
| 650 | 4 | |a capecitabine | |
| 650 | 4 | |a Xeloda | |
| 650 | 4 | |a fluoropyrimidines | |
| 650 | 4 | |a Pharmacogenetics | |
| 700 | 1 | |a Lee, Soo-Chin |4 oth | |
| 700 | 1 | |a Goh, Boon-Cher |4 oth | |
| 700 | 1 | |a Yong, Wei-Peng |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d London : Future Medicine, 2000 |g 17(2016), 15, Seite 1607-1610 |w (DE-627)320595625 |w (DE-600)2019513-8 |w (DE-576)364344261 |x 1462-2416 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2016 |g number:15 |g pages:1607-1610 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.2217/pgs-2016-0133 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 17 |j 2016 |e 15 |h 1607-1610 | ||